Genomics-guided therapies are transforming oncology, but selecting patients who are candidates for drugs matched to their tumor's biological profile is difficult.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Dec 09, 2022 |
| Journal | Med (New York, N.Y.) |
| Authors | Fröhling Stefan |
| DOI | 10.1016/j.medj.2022.11.004 |
| Source | PubMed |